Quotes for Panion Animal Health AB
- +/-
- %
- ()
Board
CEO
- Anja Holm
Chairperson of the Board
- Arne Ferstad
Board
- Jan Nilsson
- Lars Thunberg
Panion Animal Health AB
Panion Animal Health is specialised in the development of gene therapy for the treatment of epilepsy in dogs and other pets. The products consist of a number of veterinary products and other forms of treatment. Today business is operated in Europe and North America. The company was established in 2005 as a subsidiary of CombiGene. The company is based in Hässleholm.
News
- Korrigering: Sista dag för handel i Panions aktier den 27 september 2019 och sista dag för handel i Panions teckningsoptioner den 26 september 2019
- Sista dag för handel i Panion Animal Healths aktier och teckningsoptioner blir den 27 september 2019
- Panion har mottagit begäran om inlösen av minoritetsaktier och teckningsoptioner samt ansöker om avnotering
- Panion"s board of directors evaluates development plan, terminates study before any enrolment, and withdraws INAD application to avoid substantial fees.
- Panion Animal Healths extra bolagsstämma (tillika första kontrollstämma) den 6 september 2019